Clinical Trial Update: Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative Colitis

View source ↗

Summary

Clinical trial investigating golimumab's effect on gut microbiota modulation in ulcerative colitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Golimumab (golimumab)

Snippet

Sponsor: Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta | Conditions: Ulcerative Colitis | Status: COMPLETED | Results posted: 2021-07-19